A - Human Necessities – 61 – B
Patent
A - Human Necessities
61
B
A61B 5/00 (2006.01) A61B 6/00 (2006.01) A61K 9/20 (2006.01) A61K 49/00 (2006.01)
Patent
CA 2594328
This invention is directed to myocardial imaging of human patients having a history of asthma or bronchospasm. In particular, the present invention uses binodenoson as a pharmacological stressor in conjunction with any one of several noninvasive and invasive diagnostic procedures available. For example, intravenous administration may be used in conjunction with a radiopharmaceutical agent and myocardial perfusion imaging to assess the severity of myocardial ischemia.
L'invention concerne une imagerie myocardique de patients humains ayant souffert dans le passé d'asthme ou de bronchospasme. Plus précisément, l'invention concerne l'utilisation de binodenoson comme agent stressant pharmacologique, conjointement avec une procédure diagnostique quelconque parmi plusieurs procédures diagnostiques non invasives et invasives disponibles. Par exemple, une administration intraveineuse peut être utilisée conjointement avec un agent radiopharmaceutique et une imagerie de perfusion myocardique, de manière à évaluer la gravité de l'ischémie myocardique.
King Pharmaceuticals Research & Development Inc.
Smart & Biggar
LandOfFree
Method of detecting myocardial dysfunction in patients... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of detecting myocardial dysfunction in patients..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of detecting myocardial dysfunction in patients... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1882734